Brief: China Resources Pharmaceutical Says Qtrly Revenue Of Dong-E-E-Jiao RMB1.07 Bln Vs RMB890.4 Mln
April 26 (Reuters) - Dong-E-E-Jiao Co Ltd 000423.SZ :
* QTRLY REVENUE OF DONG-E-E-JIAO RMB1.07 BILLION VERSUS
RMB890.4
MILLION
* QTRLY NET PROFIT RMB230.5 MILLION VERSUS RMB114.7 MILLION
FOR
DONG-E-E-JIAO COMPANY
Source text for Eikon: ID:nHKS4y8Rv9
Further company coverage: 000423.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million